NEOPLASM
Clinical trials for NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new NEOPLASM trials appear
Sign up with your email to follow new studies for NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Promising cancer drug trial halted early
Disease control TerminatedThis study tested a new experimental drug called SAR444200, alone or with other cancer treatments, in 33 adults with advanced solid tumors that had spread and were no longer responding to standard therapies. The main goals were to check safety and find the right dose. However, th…
Matched conditions: NEOPLASM
Phase: PHASE1, PHASE2 • Sponsor: Sanofi • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
Experimental HER2 drug trial halted early – what we know
Disease control TerminatedThis early-stage trial tested a new drug called SAR443216 in 44 adults with advanced HER2-positive cancers (like breast, lung, or stomach cancer) that had stopped responding to standard treatments. The main goals were to check safety and find the right dose. The study was termina…
Matched conditions: NEOPLASM
Phase: PHASE1 • Sponsor: Sanofi • Aim: Disease control
Last updated May 11, 2026 20:48 UTC